T2 Biosystems, Inc. (TTOO)
USD 0.35
(2.88%)
USD 0.35
(2.88%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -19.19 USD | 98.46% |
| 2022 | -1242.48 USD | 26.21% |
| 2021 | -1683.72 USD | 16.97% |
| 2020 | -2027.86 USD | 70.76% |
| 2019 | -6934.20 USD | -5398.1% |
| 2018 | -126.12 USD | 35.09% |
| 2017 | -194.29 USD | 7.77% |
| 2016 | -210.66 USD | 4.64% |
| 2015 | -220.91 USD | 38.95% |
| 2014 | -361.85 USD | 75.5% |
| 2013 | -1476.89 USD | -1330.12% |
| 2012 | -103.27 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -2.66 USD | -27.88% |
| 2024 Q2 | -0.66 USD | 75.94% |
| 2023 Q1 | -146.98 USD | 4.94% |
| 2023 Q4 | -2.08 USD | 39.71% |
| 2023 Q3 | -3.45 USD | 55.99% |
| 2023 Q2 | -7.84 USD | 94.67% |
| 2023 FY | - USD | 98.46% |
| 2022 Q2 | -595.33 USD | -11.53% |
| 2022 Q4 | -154.62 USD | 51.03% |
| 2022 FY | - USD | 26.21% |
| 2022 Q1 | -533.78 USD | -46.08% |
| 2022 Q3 | -315.75 USD | 46.96% |
| 2021 Q1 | -359.58 USD | -7.43% |
| 2021 Q4 | -365.41 USD | 13.21% |
| 2021 Q3 | -421.01 USD | -4.54% |
| 2021 FY | - USD | 16.97% |
| 2021 Q2 | -402.72 USD | -12.0% |
| 2020 FY | - USD | 70.76% |
| 2020 Q1 | -1089.02 USD | -7328.51% |
| 2020 Q2 | -444.12 USD | 59.22% |
| 2020 Q3 | -380.76 USD | 14.27% |
| 2020 Q4 | -334.72 USD | 12.09% |
| 2019 Q3 | -31.20 USD | 11.41% |
| 2019 FY | - USD | -5398.1% |
| 2019 Q4 | -14.66 USD | 53.01% |
| 2019 Q2 | -35.22 USD | -2.95% |
| 2019 Q1 | -34.21 USD | -99.36% |
| 2018 Q3 | -24.60 USD | 23.63% |
| 2018 FY | - USD | 35.09% |
| 2018 Q1 | -35.89 USD | -41.63% |
| 2018 Q2 | -32.21 USD | 10.25% |
| 2018 Q4 | -17.16 USD | 30.24% |
| 2017 FY | - USD | 7.77% |
| 2017 Q1 | -48.16 USD | -0.82% |
| 2017 Q2 | -50.41 USD | -4.67% |
| 2017 Q3 | -44.80 USD | 11.13% |
| 2017 Q4 | -25.34 USD | 43.44% |
| 2016 Q1 | -55.44 USD | 1.75% |
| 2016 Q4 | -47.77 USD | 6.48% |
| 2016 Q3 | -51.08 USD | 11.55% |
| 2016 Q2 | -57.75 USD | -4.17% |
| 2016 FY | - USD | 4.64% |
| 2015 Q4 | -56.43 USD | 1.47% |
| 2015 Q2 | -54.27 USD | -2.63% |
| 2015 Q1 | -52.88 USD | -16.76% |
| 2015 FY | - USD | 38.95% |
| 2015 Q3 | -57.27 USD | -5.53% |
| 2014 Q1 | -49.44 USD | -117.22% |
| 2014 Q3 | -65.36 USD | -61.3% |
| 2014 Q4 | -45.29 USD | 30.71% |
| 2014 FY | - USD | 75.5% |
| 2014 Q2 | -40.52 USD | 18.04% |
| 2013 Q4 | -22.76 USD | 31.36% |
| 2013 FY | - USD | -1330.12% |
| 2013 Q1 | -32.72 USD | 0.0% |
| 2013 Q2 | -35.82 USD | -9.47% |
| 2013 Q3 | -33.16 USD | 7.43% |
| 2012 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Bionano Genomics, Inc. | -6.81 USD | -181.791% |
| Prenetics Global Limited | -5.58 USD | -243.907% |
| Star Equity Holdings, Inc. | 7.42 USD | 358.625% |
| CareDx, Inc | -3.54 USD | -442.09% |
| Exact Sciences Corporation | -1.13 USD | -1598.23% |
| Exagen Inc. | -1.34 USD | -1332.09% |
| Inotiv, Inc. | -4.10 USD | -368.049% |
| Guardant Health, Inc. | -4.28 USD | -348.364% |
| Biodesix, Inc. | -0.64 USD | -2898.438% |
| BioNexus Gene Lab Corp. | -0.17 USD | -11188.235% |
| Precipio, Inc. | -4.51 USD | -325.499% |
| iSpecimen Inc. | -1.23 USD | -1460.163% |
| Natera, Inc. | -3.78 USD | -407.672% |
| Aspira Women's Health Inc. | -1.81 USD | -960.221% |
| Standard BioTools Inc. | -0.94 USD | -1941.489% |
| 23andMe Holding Co. | -1.40 USD | -1270.714% |
| Castle Biosciences, Inc. | -2.14 USD | -796.729% |
| Personalis, Inc. | -2.25 USD | -752.889% |
| Aclaris Therapeutics, Inc. | -1.27 USD | -1411.024% |
| Applied DNA Sciences, Inc. | -15.21 USD | -26.167% |
| OpGen, Inc. | -41.47 USD | 53.726% |
| Myriad Genetics, Inc. | -1.39 USD | -1280.576% |
| ICON Public Limited Company | 7.46 USD | 357.239% |
| NeoGenomics, Inc. | -0.70 USD | -2641.429% |
| Star Equity Holdings, Inc. | 7.42 USD | 358.625% |
| IDEXX Laboratories, Inc. | 10.17 USD | 288.692% |
| RadNet, Inc. | 0.05 USD | 40162.63% |
| MDxHealth SA | -1.66 USD | -1056.024% |
| Psychemedics Corporation | -0.72 USD | -2565.278% |
| Illumina, Inc. | -7.35 USD | -161.088% |
| Check-Cap Ltd. | -3.00 USD | -539.667% |
| Twist Bioscience Corporation | -3.60 USD | -433.056% |
| DarioHealth Corp. | -1.93 USD | -894.301% |
| Fulgent Genetics, Inc. | -5.63 USD | -240.853% |
| Sera Prognostics, Inc. | -1.16 USD | -1554.31% |
| ENDRA Life Sciences Inc. | -1.11 USD | -1628.829% |
| OPKO Health, Inc. | -0.25 USD | -7576.0% |
| Medpace Holdings, Inc. | 9.20 USD | 308.587% |
| Neogen Corporation | -0.04 USD | -44014.943% |
| Intelligent Bio Solutions Inc. | -6.38 USD | -200.784% |
| Prenetics Global Limited | -5.58 USD | -243.907% |
| Mainz Biomed B.V. | -1.62 USD | -1084.568% |
| bioAffinity Technologies, Inc. | -0.91 USD | -2008.791% |
| Trinity Biotech plc | -3.14 USD | -511.146% |
| Neuronetics, Inc. | -1.05 USD | -1727.619% |
| Sotera Health Company | 0.18 USD | 10761.111% |
| bioAffinity Technologies, Inc. | -0.91 USD | -2008.791% |